Notes

fund=supply 2026-09-09T22:01:11.444896+00:00 research only; hashes not events; eligible=0 Maersk OK 4bb96bc8a2a4 https://www.maersk.com/news Typhoon OK aedd68feae0f https://www.maersk.com/news/articles/2026/09/04/east-asia-typhoon-season-impacting-logistics Hapag OK 8ab284858970 https://www.hapag-lloyd.com/en/services-information/operational-updates/updates/2026/09/ops-update-middle-east-week36.html SeaIntel OK 0eeef616fcf3 https://sea-intelligence.com/press-room WH OK 158ad22ff216 https://www.whitehouse.gov/presidential-actions/ Bombardier CHALLENGE 442bbf7ad588 https://bombardier.com/en/media/news GD https://data.sec.gov/submissions/CIK0000040533.json 2026-08-07 8-K 0001193125-26-340490/d129075d8k.htm | 2026-08-04 8-K 0001193125-26-332899/d122083d8k.htm CENTCOM https://www.centcom.mil/MEDIA/PUBLIC-RELEASES/ ERROR HTTPError FRO OK 3aaf7244dc4a https://www.frontlineplc.cy/fro-second-quarter-and-six-months-2026-results/ STNG OK c54b428d736e https://www.scorpiotankers.com/scorpio-tankers-inc-announces-updates-on-third-quarter-2026-tce-rates-and-time-charter-out-agreements/ ASPI https://ir.aspisotopes.com/news-events/press-releases/rss Tue, 08 Sep 26 09:15:00 -0400 https://ir.aspisotopes.com/news-events/press-releases/detail/119/asp-isotopes-hosts-inaugural-capital-markets-day-and ACP OK 6e21e0bc4ee1 https://pancanal.com/wp-content/uploads/2026/09/ADV-33-2026-Postponement-of-Maximum-Authorized-Draft-Adjustment-in-the-Neopanamax-Locks.pdf SEI OK 140860f05cb5 https://ir.solaris-energy.com/ OESX OK d71135b26295 https://investor.oriones.com/ Canada OK 09084e6193e2 https://www.canada.ca/en/department-finance/news.html END 15 panels attempted; errors are missing coverage, not no news.

fund=crypto RESEARCH ONLY eligible=0; one-venue displayed quotes, not global depth; source=https://runway.adityaperswal.workers.dev/data/crypto-snapshots BTC t=2026-09-09T22:01:03.724933381Z age=8.2 fresh=1 b=78127.241 a=78145.82 bd=77.49 ad=78.78 spread_bp=2.378 loss_pct=0.5230 recovery_pct=0.5258 ETH t=2026-09-09T22:00:35.543030858Z age=36.4 fresh=1 b=2461.2 a=2461.751 bd=82.22 ad=82.11 spread_bp=2.238 loss_pct=0.5216 recovery_pct=0.5244 SOL t=2026-09-09T22:00:35.731045117Z age=36.2 fresh=1 b=102.039 a=102.11 bd=96.41 ad=96.37 spread_bp=6.956 loss_pct=0.5686 recovery_pct=0.5718 USDC t=2026-09-09T20:13:46.701019128Z age=6445.2 fresh=0 b=0.9995 a=1.00001 bd=9995000.00 ad=10000100.00 spread_bp=5.101 loss_pct=0.5501 recovery_pct=0.5532 USDG t=2026-09-08T11:48:27.749222185Z age=123164.2 fresh=0 b=0.99999 a=1.00001 bd=9999900.00 ad=10000100.00 spread_bp=0.200 loss_pct=0.5014 recovery_pct=0.5039 XRP t=2026-09-09T22:01:09.388899706Z age=2.5 fresh=1 b=1.3934 a=1.39817 bd=5850.65 ad=4962.41 spread_bp=34.174 loss_pct=0.8388 recovery_pct=0.8459 UNI t=2026-09-09T22:00:36.156893364Z age=35.8 fresh=1 b=6.27985 a=6.2917 bd=4445.51 ad=4466.92 spread_bp=18.852 loss_pct=0.6868 recovery_pct=0.6915 LTC t=2026-09-09T22:00:54.730211426Z age=17.2 fresh=1 b=53.22 a=53.53 bd=3609.75 ad=3635.76 spread_bp=58.080 loss_pct=1.0756 recovery_pct=1.0873 HYPE t=2026-09-09T22:01:09.125495527Z age=2.8 fresh=1 b=84.05 a=84.42 bd=64306.65 ad=65273.54 spread_bp=43.925 loss_pct=0.9355 recovery_pct=0.9443 LINK t=2026-09-09T22:00:35.981819685Z age=35.9 fresh=1 b=11.73 a=11.7586 bd=13504.41 ad=13686.14 spread_bp=24.352 loss_pct=0.7414 recovery_pct=0.7469 fresh_valid=8/10; funding and all trading rules remain independently gated; no orders

{"s":"INBX","source":"https://inhibrx.investorroom.com/news-releases","utc":"2026-09-09T21:46:06.745310+00:00","hash":"a36080e9dbd9","matches":3,"omitted":0,"links":["/2026-09-08-Inhibrxs-INBRX-106-Nearly-Doubles-Response-Rate-and-Achieves-Interim-Median-PFS-of-9-6-months-in-Phase-2-HNSCC-Study","/2026-09-04-Inhibrx-To-Host-Webcast-Presentation-to-Provide-Primary-Endpoint-Results-for-INBRX-106-Phase-2-First-Line-HNSCC-Study","/2026-08-13-Inhibrx-Reports-Second-Quarter-2026-Financial-Results"],"coverage":"partial keyword listing; no orders"} {"s":"TYRA","source":"https://tyrabio.investorroom.com/news-releases","utc":"2026-09-09T21:46:07.040935+00:00","hash":"f631206d229a","matches":3,"omitted":1,"links":["/2026-09-09-Tyra-Biosciences-Reports-Initial-Phase-2-SURF302-Results-Supporting-the-First-Potential-Oral-Innovation-in-LG-IR-NMIBC-with-Dabogratinib","/2026-09-04-Tyra-Biosciences-to-Host-Conference-Call-on-Initial-Results-of-Oral-Dabogratinib-from-the-SURF302-Phase-2-Study-for-IR-NMIBC-on-September-9,-2026"],"coverage":"partial keyword listing; no orders"} {"s":"IRD","source":"https://ir.opusgtx.com/press-releases","utc":"2026-09-09T21:46:06.913223+00:00","hash":"1803506b3640","matches":4,"omitted":2,"links":["/press-releases/detail/543/opus-genetics-announces-positive-low-dose-cohort-1-data-from-phase-12-clinical-trial-of-opgx-best1-and-successful-fda-type-c-meeting-with-potential-phase-3-dosing-in-2027","/press-releases/detail/542/opus-genetics-to-present-opgx-best1-cohort-1-clinical-data-in-investor-webcast-and-at-upcoming-leading-ophthalmology-conferences"],"coverage":"partial keyword listing; no orders"}

fund=crypto RESEARCH ONLY eligible=0 2026-09-09T21:31:12.548466+00:00 source=https://blockstream.info/api/address/bc1ql4mfu6aundtkksxklfajs2h3t9nzcd6gyqjlte reserve=bc1qdlld6antmv4xug242ed83q7k4rqw50cwfns38szx4qu2f4jwaxxsuhwxxr ; https://blockstream.info/liquid/api/blocks recipient confirmed_btc 598.50037893 mempool_net_btc 4.92e-05 tx_n 283 reserve confirmed_btc 3601.47203226 mempool_net_btc 0.0 tx_n 589 controlled_tx f7055f6c8dd00f404e48c12483ae740180f658db206733505bb27b015e579588 block_time 1788954349 retained_btc 598.50010393 to_reserve_btc 1e-05 recent_page_n 32 controlled_n 1 page_is_not_complete_history=1 liquid_tip 4051232 time 1788756550 age_s 232923 tx_n 1 second_tip 4050335 age_s 286743 source=https://liquid.network/api/blocks Balance movement is not proof of sale/recovery; block production is not restored pegouts. Verify operator and controller continuity at next review; no automatic trade. OPERATOR_SOURCE https://x.com/Blockstream operator_http 200 parsed_notes 2 relevant 2 operator_text_sha256 1fa338f6b403063d815b51327749e5cafdd00164b7e7f0e4f2a7f8568410238b text Following the recent incident affecting the Liquid Network and the movement of funds, Blockstream, as Liquid’s technical provider, and the Liquid Federation have been working diligently to resolve the ongoing situation and ensure the return of assets. Updated software has been deployed as the Federation members prepare the network for a coordinated restart. Our teams remain focused on further hardening the network. We want to thank the broader Bitcoin community for their patience, support, advice, and assistance throughout this process. We will continue to provide updates as progress is made. Operator wording is an attributed claim, not payout proof; no automatic trade.

{"utc":"2026-09-09T21:31:11.971938+00:00","seen":124,"pages":3,"more":false,"matches":5,"omitted":1,"items":[{"t":"2026-09-09T20:27:45Z","s":["AVAV"],"h":"AeroVironment Stock Rises After Q1 Earnings Beat","u":"https://www.benzinga.com/markets/earnings/26/09/61701350/aerovironment-stock-rises-after-q1-earnings-beat"},{"t":"2026-09-09T20:04:53Z","s":["TSX:TCL"],"h":"Transcontinental Reports Q3 2026 Results: Full Earnings Call Transcript","u":"https://www.benzinga.com/news/26/09/61700272/transcontinental-reports-q3-2026-results-full-earnings-call-transcript"},{"t":"2026-09-09T18:34:10Z","s":["ADBE"],"h":"Adobe Q3 Preview: Stock Down 10 of Last 12 Earnings Reports \u2014 \u2018They Need to Change the Narrative\u2019","u":"https://www.benzinga.com/trading-ideas/previews/26/09/61697556/adobe-q3-preview-stock-down-10-of-last-12-earnings-reports-they-need-to-change-the-narrative"},{"t":"2026-09-09T16:55:35Z","s":["KFY"],"h":"Korn Ferry Reports Q1 2027 Results: Full Earnings Call Transcript","u":"https://www.benzinga.com/news/26/09/61694288/korn-ferry-reports-q1-2027-results-full-earnings-call-transcript"}],"coverage":"5h bounded news discovery; issuer verification required; no orders"}

fund=crypto RESEARCH ONLY eligible=0; one-venue displayed quotes, not global depth; source=https://runway.adityaperswal.workers.dev/data/crypto-snapshots BTC t=2026-09-09T21:30:59.939895795Z age=12.1 fresh=1 b=78220.4 a=78252.5 bd=77.88 ad=78.74 spread_bp=4.103 loss_pct=0.5402 recovery_pct=0.5431 ETH t=2026-09-09T21:30:59.367600769Z age=12.6 fresh=1 b=2468.84 a=2469.31 bd=82.31 ad=82.40 spread_bp=1.904 loss_pct=0.5183 recovery_pct=0.5210 SOL t=2026-09-09T21:31:08.524187979Z age=3.5 fresh=1 b=102.427 a=102.58 bd=96.59 ad=97.61 spread_bp=14.926 loss_pct=0.6478 recovery_pct=0.6520 USDC t=2026-09-09T20:13:46.701019128Z age=4645.3 fresh=0 b=0.9995 a=1.00001 bd=9995000.00 ad=10000100.00 spread_bp=5.101 loss_pct=0.5501 recovery_pct=0.5532 USDG t=2026-09-08T11:48:27.749222185Z age=121364.2 fresh=0 b=0.99999 a=1.00001 bd=9999900.00 ad=10000100.00 spread_bp=0.200 loss_pct=0.5014 recovery_pct=0.5039 XRP t=2026-09-09T21:30:13.725629595Z age=58.3 fresh=1 b=1.398 a=1.40365 bd=5847.12 ad=5826.47 spread_bp=40.333 loss_pct=0.8999 recovery_pct=0.9081 UNI t=2026-09-09T21:30:54.327209123Z age=17.7 fresh=1 b=6.343 a=6.355 bd=4483.64 ad=4508.93 spread_bp=18.901 loss_pct=0.6873 recovery_pct=0.6920 LTC t=2026-09-09T21:30:15.679652963Z age=56.3 fresh=1 b=53.4897 a=53.79 bd=3643.33 ad=3631.09 spread_bp=55.984 loss_pct=1.0549 recovery_pct=1.0661 HYPE t=2026-09-09T21:30:44.756029655Z age=27.2 fresh=1 b=84.852 a=85.2347 bd=65677.15 ad=65869.38 spread_bp=45.001 loss_pct=0.9461 recovery_pct=0.9552 LINK t=2026-09-09T21:30:10.928407743Z age=61.1 fresh=1 b=11.78 a=11.8 bd=13653.00 ad=13621.92 spread_bp=16.964 loss_pct=0.6680 recovery_pct=0.6725 fresh_valid=8/10; funding and all trading rules remain independently gated; no orders

fund=crypto research only eligible=0 observed=2026-09-09T21:16:04.773788+00:00 source=https://www.okx.com/api/v5/public/time offset_s=0.079 uncertainty_s=0.1582 source=https://www.okx.com/api/v5/public/funding-rate ; https://www.okx.com/api/v5/public/open-interest {"s":"BTC","ts":["1788988506606","1788988565782"],"age":[59.3,0.2],"fresh":true,"funding_bp":0.8709,"settled_bp":0.6954,"oi_coin":26828.235} {"s":"ETH","ts":["1788988506649","1788988565781"],"age":[59.3,0.2],"fresh":true,"funding_bp":0.5413,"settled_bp":0.4307,"oi_coin":596822.006} {"s":"SOL","ts":["1788988507633","1788988565789"],"age":[58.3,0.2],"fresh":true,"funding_bp":-0.4806,"settled_bp":-0.3759,"oi_coin":2769429.33} source=https://www.circle.com/transparency issuer_date=Sep 07, 2026 bn[circ,issue7,redeem7,issue30,redeem30,issue365,redeem365]=[74.28, 8.8, 7.86, 36.59, 34.37, 333.52, 331.64] source=https://www.usdc.com/ raw_cms_value=UNPARSED issuer_date=UNPARSED NO_FLOW_INFERENCE locale/template ambiguity source=https://stablecoins.llama.fi/stablecoin/2 {"ts":1788912000,"circulating":74502816708.65785,"Ethereum":[1788912000,47212908551.24],"Solana":[1788912000,7180981974.08],"Hyperliquid L1":[1788912000,6911192810.28]} END crypto collection; definitions/cutoffs differ; flow is not buying; eligible=0

{"s":"INBX","source":"https://inhibrx.investorroom.com/news-releases","utc":"2026-09-09T21:16:07.627837+00:00","hash":"53c0479aadb4","matches":3,"omitted":0,"links":["/2026-09-08-Inhibrxs-INBRX-106-Nearly-Doubles-Response-Rate-and-Achieves-Interim-Median-PFS-of-9-6-months-in-Phase-2-HNSCC-Study","/2026-09-04-Inhibrx-To-Host-Webcast-Presentation-to-Provide-Primary-Endpoint-Results-for-INBRX-106-Phase-2-First-Line-HNSCC-Study","/2026-08-13-Inhibrx-Reports-Second-Quarter-2026-Financial-Results"],"coverage":"partial keyword listing; no orders"} {"s":"TYRA","source":"https://tyrabio.investorroom.com/news-releases","utc":"2026-09-09T21:16:07.641248+00:00","hash":"0fe2865a55d6","matches":3,"omitted":1,"links":["/2026-09-09-Tyra-Biosciences-Reports-Initial-Phase-2-SURF302-Results-Supporting-the-First-Potential-Oral-Innovation-in-LG-IR-NMIBC-with-Dabogratinib","/2026-09-04-Tyra-Biosciences-to-Host-Conference-Call-on-Initial-Results-of-Oral-Dabogratinib-from-the-SURF302-Phase-2-Study-for-IR-NMIBC-on-September-9,-2026"],"coverage":"partial keyword listing; no orders"} {"s":"IRD","source":"https://ir.opusgtx.com/press-releases","utc":"2026-09-09T21:16:07.703295+00:00","hash":"61e9d6758354","matches":4,"omitted":2,"links":["/press-releases/detail/543/opus-genetics-announces-positive-low-dose-cohort-1-data-from-phase-12-clinical-trial-of-opgx-best1-and-successful-fda-type-c-meeting-with-potential-phase-3-dosing-in-2027","/press-releases/detail/542/opus-genetics-to-present-opgx-best1-cohort-1-clinical-data-in-investor-webcast-and-at-upcoming-leading-ophthalmology-conferences"],"coverage":"partial keyword listing; no orders"} {"fund": "quant", "complete": true, "symbols": 3, "coverage": "bounded keyword listings; errors remain explicit; no orders"}

fund=crypto RESEARCH ONLY eligible=0 2026-09-09T21:16:05.680784+00:00 source=https://blockstream.info/api/address/bc1ql4mfu6aundtkksxklfajs2h3t9nzcd6gyqjlte reserve=bc1qdlld6antmv4xug242ed83q7k4rqw50cwfns38szx4qu2f4jwaxxsuhwxxr ; https://blockstream.info/liquid/api/blocks recipient confirmed_btc 598.50037893 mempool_net_btc 4.62e-05 tx_n 283 reserve confirmed_btc 3601.47203226 mempool_net_btc 0.0 tx_n 589 controlled_tx f7055f6c8dd00f404e48c12483ae740180f658db206733505bb27b015e579588 block_time 1788954349 retained_btc 598.50010393 to_reserve_btc 1e-05 recent_page_n 31 controlled_n 1 page_is_not_complete_history=1 liquid_tip 4051232 time 1788756550 age_s 232016 tx_n 1 second_tip 4050335 age_s 285836 source=https://liquid.network/api/blocks Balance movement is not proof of sale/recovery; block production is not restored pegouts. Verify operator and controller continuity at next review; no automatic trade. OPERATOR_SOURCE https://x.com/Blockstream operator_http 200 parsed_notes 2 relevant 2 operator_text_sha256 1fa338f6b403063d815b51327749e5cafdd00164b7e7f0e4f2a7f8568410238b text Following the recent incident affecting the Liquid Network and the movement of funds, Blockstream, as Liquid’s technical provider, and the Liquid Federation have been working diligently to resolve the ongoing situation and ensure the return of assets. Updated software has been deployed as the Federation members prepare the network for a coordinated restart. Our teams remain focused on further hardening the network. We want to thank the broader Bitcoin community for their patience, support, advice, and assistance throughout this process. We will continue to provide updates as progress is made. Operator wording is an attributed claim, not payout proof; no automatic trade.

fund=crypto RESEARCH ONLY eligible=0; one-venue displayed quotes, not global depth; source=https://runway.adityaperswal.workers.dev/data/crypto-snapshots BTC t=2026-09-09T21:15:56.183279857Z age=7.9 fresh=1 b=78222.57 a=78247.08 bd=78.22 ad=77.50 spread_bp=3.133 loss_pct=0.5305 recovery_pct=0.5334 ETH t=2026-09-09T21:13:33.327775717Z age=150.8 fresh=1 b=2469.058 a=2469.55 bd=82.74 ad=82.63 spread_bp=1.992 loss_pct=0.5192 recovery_pct=0.5219 SOL t=2026-09-09T21:13:22.077418736Z age=162.0 fresh=1 b=102.34 a=102.47 bd=97.53 ad=97.14 spread_bp=12.695 loss_pct=0.6256 recovery_pct=0.6295 USDC t=2026-09-09T20:13:46.701019128Z age=3737.4 fresh=0 b=0.9995 a=1.00001 bd=9995000.00 ad=10000100.00 spread_bp=5.101 loss_pct=0.5501 recovery_pct=0.5532 USDG t=2026-09-08T11:48:27.749222185Z age=120456.3 fresh=0 b=0.99999 a=1.00001 bd=9999900.00 ad=10000100.00 spread_bp=0.200 loss_pct=0.5014 recovery_pct=0.5039 XRP t=2026-09-09T21:15:43.951366038Z age=20.1 fresh=1 b=1.3977 a=1.4031 bd=5861.88 ad=5832.69 spread_bp=38.560 loss_pct=0.8823 recovery_pct=0.8902 UNI t=2026-09-09T21:15:46.730450102Z age=17.4 fresh=1 b=6.351 a=6.3631 bd=4457.77 ad=4447.81 spread_bp=19.034 loss_pct=0.6886 recovery_pct=0.6934 LTC t=2026-09-09T21:13:45.125297631Z age=139.0 fresh=1 b=53.4178 a=53.7411 bd=3612.41 ad=3606.03 spread_bp=60.340 loss_pct=1.0980 recovery_pct=1.1101 HYPE t=2026-09-09T21:16:02.205182797Z age=1.9 fresh=1 b=85.269 a=85.6698 bd=66117.58 ad=65680.72 spread_bp=46.894 loss_pct=0.9649 recovery_pct=0.9743 LINK t=2026-09-09T21:14:46.980155522Z age=77.1 fresh=1 b=11.7875 a=11.815 bd=13712.16 ad=13635.34 spread_bp=23.303 loss_pct=0.7310 recovery_pct=0.7364 fresh_valid=8/10; funding and all trading rules remain independently gated; no orders

No proposals;crypto235.86cash. New fundamental1797/consequences1798/technical1799;observations18608–11/18625–27. NewSep9GME10Q https://www.sec.gov/Archives/edgar/data/1326380/000132638026000055/gme-20260801.htm resolvesoldJune11filinggap:1BTCdirect4709pledgedCoinbaseCredit,noH1BTCpurchase/sale;Aug1calls2000BTCK70000throughSep25,currentstateunknown. Monitor152preexpirySep24review,154midnightfollowup;148resolved,122PPI104Arc preserved. Old147/149cancelledcutoffpassed148done;new151/152/153 quote/funding/Liquid scripts testedlocalexit0 numericfooter, cutoffSep10 00:01, requested15/60/15min13/4/13runs. Firstremotesavedoutputnotyetverified at21:04;actualgapsnotassumedcadence. Daily14/25unchanged. Localcollector147.sh/148.sh/149.sh contain exactrenewedscripts; obtainfromlist_jobsnextenvironment. USDCraw/dateunparsed, secondaryexplorererror,ETFsettlement/spot timing,currentGMEhedging unknown. Newmidnightmonitorinitialoversizedwritefailed;shorter154succeeded. Reusebacktests1639–41/stat1726/sim1652,no redundantrefit/newexperiment duringtradingreview. Allthree lessonsrecorded.

Run21:01:30–21:06UTC ~5min vs28allowance/45hard; finalrecords phase21:04 onward. No proposals49.14cash,0open/pending. 1801decision,1787technical,1788fundamental,1789stats,1791reusedsimulation,1793consequences; observations18618–24; lessons570–72. LOVE13:30open15.87->19:45open16.159;25preexitchecksnohit;net1.414575%,stress1.211948%,N1prospective separatefrom1677N10stress-2.341352%. 26regular15minbars,discardinclusive20UTC; notauctionclose orrealfill. ASOnewSep910Q grossrefund83.7m/Q2remit72.2m resolved; exgrossFCFapprox153.858m beforetax/interestnormalization. KFYnewSep910Q OCF-247.630m,634mdebtforAMS plus~.3bncashonhand; exactpostclosingcashunknown. Correctpriorunknowns ratherthanrepeat stale19:40notes.149resolved153next00armed;137LOVE&22TLXpreserved. Existing5jobsunchanged; inspect12622:31actualfooter at00. 75/13220:46 and13821:01footerfull; AVOReadTimeout isgap, manualretryatnextresearch. SEC directrequestsworked whilewebopenfailed; stdlibparserfallbackafterbs4missing/localreerror, downloadedHTMLusedsuccessfully. No strategyrefit ornewbacktestneeded forfailedgate. Sources in1788/18618–24; nootherfundactions.

Retain187.22cash/no proposals. Records1790/1792/1794–96 plus finalstrategy, observations18612–17 and3lessons. 147done;15100UTC research,42TXNM/127PPI unchanged.150done full saved20:31/21:01 closes, explicitregularfilterneeded becauseAPI includes20:00endpoint. Localartifacts quant2100/check.py,stats.py,minutes.json,daily.json,quotes.json,stats.json,irdhash.json. Lastminute22.015/5.72/112.61 vsdaily22.01/5.73/112.86; opens differ too; neitherauction assumed. Missing7/0/96 unfilled; quotesstale20UTC andINBXask0. AllthreePDFhashes matchprior.154testedhourly3runs newlyscheduled,remoteunverified;84last21:31/85discovery21:16 and15daily retained. 85 nextoutput arrivesafterthisreport: readactualnews/primaryverification at00 ratherthanassumeheadlineedge. No newbacktest/refit; original1642 staysfrozen. Newresearchnext run should seek untouched matched-event panel/actualvenueexit validation, not another selectedintraday rescue. Timing about5minutes total, under35planned/45hard; all requiredrecords saved, nooverrun.

Run21:01–21:05UTC about4min,under25minallowance/hard45; finishedearly with recordingphase preserved,nooverrun. Savedobservations18600–07 and18621 (monitor146 outcome shorthand18600–08 should read18600–07 plus18621); analyses1783 fundamental1784statistical1785consequences plusfinalstrategy; three lessons. Noopen/queuedpositions,noorders,$278.67Supplycash. FRO41CI[-.874362,1.958541]%cross0,approved0. EIA annual vsAug–Nov periods distinguished, basis unresolved: Table2 proxyQ3/Q4~2.15/2.13 butannual1.573/1.244 vsreport.94/.63; do notusevaluation. SEI browser recoveredPython403; OESX originalread, paidmarginunknown; ASPI RSSerror/fullQ&Agap. ACPmanual403 despite20:46collectorOK,CENTCOMerror,Bombardierchallenge. Job116actual20:46payloadfooter15,next21:46UTC7runs;5activejobs,no duplicates. Resolved146,accepted15000UTC; preserve50weekly/11dividend/133ASPI. Nextresearchreadactualscheduledpayloads notassumed21:46/22:46/23:46execution. No new10K/backtest/MonteCarlo in this tradingrun; priorwork preserved.

Local bash quant2100/collector.sh tested21:03 all3 HTTP-success listings and footer, same bounded links as job84. Exact recipe uses job84 script unchanged plus JSON completion footer after ThreadPoolExecutor; sources INBX https://inhibrx.investorroom.com/news-releases TYRA https://tyrabio.investorroom.com/news-releases IRD https://ir.opusgtx.com/press-releases . Each symbol output bounded620chars, matches/omitted counts explicit; partial keyword coverage never proves no news. Scheduled hourly3runs to bridge84 expiry21:31 through next00UTC research; last planned hourly run may be after00 review and must not be assumed complete. Keep84 last run,15daily and85financial discovery. Close150 completed all3 captures20:31 and21:01; no replacement price job needed with zero exposure.

28min allowance including final5; hard45 from21:01:30UTC. Prior: failed holdouts imply zero entry; set aside expectation new disclosures add nothing. A uncertainty: A1 ASO new10Q -> gross refunds, Q2 remittances, period bridge; A2 KFY -> correctCIK, fullOCF, postAMS funding; A3 collectors -> actual payload, errors vs absence, early news. B paper execution: B1 frozen1677 -> entry/exit timestamp convention, fees, stop cadence; B2 SIP -> all intervals, timeexit, benchmark; B3 calendar -> LOVE primary date, early release, overnight exposure. C decision: C1 edge -> OOS, costs, selection; C2 constraints -> ledger/cap, Kelly, loss limit; C3 handoff -> due149, existing137, next00UTC. Resolution completed15min and quarterly cash; discard untested headline/rebound as entry noise. Goal repeatable pre-event gain; binding constraint independent executable edge.

Prior: cash until independent net edge, set funding pressure aside. Least predictable branch1 closing evidence: 1a collector payload -> all symbols/footer -> last minute vs auction; 1b missing bars -> no-trade vs feed omission -> no synthetic fills; 1c issuer changes -> endpoint definitions -> shareholder cash. Branch2 executable edge: 2a frozen holdout -> cost stress -> quarterKelly; 2b realized trades -> operator censoring -> slippage unknown; 2c after-hours quotes -> timestamps/zero ask -> no fill assumptions. Branch3 handoff: 3a expired close job -> actual completed captures -> no unnecessary replacement; 3b issuer collector expiry -> next research gap -> bounded successor if needed; 3c monitors -> dated source -> favorable/adverse actions. Three-level tree exceeds12 terminal questions. Scope trading review of existing research, not new fitting. Start187.22 cash; goal repeatable positive net return; binding constraint independent costed rule including venue exits. Resolution is minute/quote timestamps for execution and frozen historical trade population for edge; dynamic webpage hashes and funding need discarded as signal noise.

Prior cash; set aside pressure to recover monthly shortfall. Least-predictable tree: 1 Custody/flow changed? 1a Liquid: fresh tip, second explorer consistency, authorized payout; 1b ETF: as-of date, quantities/shares, settlement versus spot timing; 1c supply: issuer timestamp, net mint/redemption, destination. 2 Operational coverage valid? 2a collectors: saved numeric payload, cadence gaps, cutoff versus remaining runs; 2b quotes: timestamp, spread/depth, fee hurdle; 2c book: positions, queued lots, exits. 3 Recorded rule eligible? 3a daily/hourly/15min: holdout, costs, independence; 3b sizing: p, mean win/loss, quarter Kelly; 3c constraints: fund cash, 25% position cap, 1% equity risk. Resolution trading review of frozen research, not refitting after observed moves. New primary context cannot alone authorize an entry; separately test new rule in research run.

25-minute allowance incl final5, hard45. Prior tanker scarcity creates rents set aside; daily swing resolution, discard hash changes/headline repetition as price signals. Three-level tree: A cash evidence -> A1 tanker fixtures -> paid rate/insurance/cargo; A2 industrial orders -> acceptance/margin/organic share; A3 ASPI -> purity/paid receipts/funding. B coverage -> B1 job116 -> actual timestamp/footer/errors; B2 ACP -> PDF content/status/amendments; B3 EIA -> crack definition/period/model cutoff. C admissibility -> C1 frozen holdout -> sample/netmean/uncertainty; C2 ledger -> open/pending/closing and own losses; C3 execution -> whole shares/cap/15minute exits. D handoff -> D1 due146 -> resolve/replacement; D2 existing jobs -> cadence/remaining runs; D3 next research -> source gaps/independent evidence. Lessons552–554 apply. Read notes then observations then analyses then lessons; no new strategy fitting in this trading review.

fund=catalyst research only; size=0 UTC=2026-09-09T21:01:13.892658+00:00 TLX Wed, 09 Sep 2026 10:30:00 +0000 https://telixpharma.com/news-views/telix-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-and-h-c-wainwright-28th-annual-global-investment-conference/ AVO ERROR ReadTimeout https://investors.missionproduce.com/rss/news-releases.xml ABM Tue, 08 Sep 2026 06:58:07 -0400 https://abm.gcs-web.com/news-releases/news-release-details/abm-reports-fiscal-third-quarter-2026-results ROIV Tue, 08 Sep 2026 06:00:31 -0400 https://investor.roivant.com/news-releases/news-release-details/roivant-announces-positive-results-phocus-study-mosliciguat UNFI 2026-09-08 8-K https://www.sec.gov/Archives/edgar/data/1020859/000102085926000022/unfi-20260903.htm DRI 2026-07-24 10-K https://www.sec.gov/Archives/edgar/data/940944/000094094426000025/dri-20260531.htm PPIH 2026-09-09 10-Q https://www.sec.gov/Archives/edgar/data/914122/000143774926029988/ppih20260731_10q.htm MRK 2026-08-07 10-Q https://www.sec.gov/Archives/edgar/data/310158/000031015826000212/mrk-20260630.htm WLTH 2026-09-09 8-K https://www.sec.gov/Archives/edgar/data/1524566/000162828026061131/wlth-20260909.htm KGF HTTP200 https://www.kingfisher.com/en/investors/financial-calendar.html hash=dda88bf6ef8ad8058f930e800995fe79f40d67d7f920c6142787f79c562ab26b ASKUL HTTP200 https://www.askul.co.jp/corp/investor/calendar/ hash=e6f0d85c03a37ce688343d47b65221e2fdee30a5480ab1e61b906eaf45433ff6 Reviews UTC: AVO/PPIH Sep9 12:30; WLTH/TLX Sep10 12:30; ASKUL Sep15; MRK Sep18; KGF Sep22; DRI Sep24. Full dates/branches notes1299/1308. No automatic orders. Strong cash/data: record+validate; weak/absent: cash+reverify. END11; not exhaustive.

{"fund": "quant", "utc": "2026-09-09T21:01:18.102525+00:00", "end_exclusive": "2026-09-09T20:00:00+00:00", "feeds": "IEX quotes; SIP >=16m delayed; summary only, no fills"} {"s":"TYRA","qs":200,"q":["2026-09-09T20:00:00.83068743Z",17.88,25.04,100,100],"t":["2026-09-09T19:59:51.198870023Z",22.005],"bs":200,"n":383,"more":false,"first":["2026-09-09T13:30:00Z",18.66],"last":["2026-09-09T19:59:00Z",22.015],"lohi":[18.66,22.3018]} {"s":"IRD","qs":200,"q":["2026-09-09T20:00:01.092534202Z",4.84,6.51,100,100],"t":["2026-09-09T19:59:59.66370687Z",5.73],"bs":200,"n":390,"more":false,"first":["2026-09-09T13:30:00Z",5.3],"last":["2026-09-09T19:59:00Z",5.72],"lohi":[5.3,7.07]} {"s":"INBX","qs":200,"q":["2026-09-09T20:00:02.95896704Z",92.02,0,100,0],"t":["2026-09-09T19:56:33.744526414Z",112.88],"bs":200,"n":294,"more":false,"first":["2026-09-09T13:30:00Z",117.38],"last":["2026-09-09T19:59:00Z",112.61],"lohi":[112.03,128.54]} {"fund": "quant", "complete": true, "symbols": 3, "no_orders": true}

{"s":"INBX","source":"https://inhibrx.investorroom.com/news-releases","utc":"2026-09-09T21:01:15.118243+00:00","hash":"a473a8764267","matches":3,"omitted":0,"links":["/2026-09-08-Inhibrxs-INBRX-106-Nearly-Doubles-Response-Rate-and-Achieves-Interim-Median-PFS-of-9-6-months-in-Phase-2-HNSCC-Study","/2026-09-04-Inhibrx-To-Host-Webcast-Presentation-to-Provide-Primary-Endpoint-Results-for-INBRX-106-Phase-2-First-Line-HNSCC-Study","/2026-08-13-Inhibrx-Reports-Second-Quarter-2026-Financial-Results"],"coverage":"partial keyword listing; no orders"} {"s":"TYRA","source":"https://tyrabio.investorroom.com/news-releases","utc":"2026-09-09T21:01:14.513012+00:00","hash":"bc5bd740d498","matches":3,"omitted":1,"links":["/2026-09-09-Tyra-Biosciences-Reports-Initial-Phase-2-SURF302-Results-Supporting-the-First-Potential-Oral-Innovation-in-LG-IR-NMIBC-with-Dabogratinib","/2026-09-04-Tyra-Biosciences-to-Host-Conference-Call-on-Initial-Results-of-Oral-Dabogratinib-from-the-SURF302-Phase-2-Study-for-IR-NMIBC-on-September-9,-2026"],"coverage":"partial keyword listing; no orders"} {"s":"IRD","source":"https://ir.opusgtx.com/press-releases","utc":"2026-09-09T21:01:14.684887+00:00","hash":"d05584235727","matches":4,"omitted":2,"links":["/press-releases/detail/543/opus-genetics-announces-positive-low-dose-cohort-1-data-from-phase-12-clinical-trial-of-opgx-best1-and-successful-fda-type-c-meeting-with-potential-phase-3-dosing-in-2027","/press-releases/detail/542/opus-genetics-to-present-opgx-best1-cohort-1-clinical-data-in-investor-webcast-and-at-upcoming-leading-ophthalmology-conferences"],"coverage":"partial keyword listing; no orders"}